Bastiaan E. de Galan and Marinette van der Graaf contributed equally to this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Chronic hyperglycaemia in type 1 diabetes affects the structure and functioning of the brain, but the impact of recurrent hypoglycaemia is unclear. Changes in the neurochemical profile have been linked to loss of neuronal function. We therefore aimed to investigate the impact of type 1 diabetes and burden of hypoglycaemia on brain metabolite levels, in which we assumed the burden to be high in individuals with impaired awareness of hypoglycaemia (IAH) and low in those with normal awareness of hypoglycaemia (NAH).
We investigated 13 non-diabetic control participants, 18 individuals with type 1 diabetes and NAH and 13 individuals with type 1 diabetes and IAH. Brain metabolite levels were determined by analysing previously obtained 1H magnetic resonance spectroscopy data, measured under hyperinsulinaemic–euglycaemic conditions.
Brain glutamate levels were higher in participants with diabetes, both with NAH (+15%, p = 0.013) and with IAH (+19%, p = 0.003), compared with control participants. Cerebral glutamate levels correlated with HbA1c levels (r = 0.40; p = 0.03) and correlated inversely (r = −0.36; p = 0.04) with the age at diagnosis of diabetes. Other metabolite levels did not differ between groups, apart from an increase in aspartate in IAH.
In conclusion, brain glutamate levels are elevated in people with type 1 diabetes and correlate with glycaemic control and age of disease diagnosis, but not with burden of hypoglycaemia as reflected by IAH. This suggests a potential role for glutamate as an early marker of hyperglycaemia-induced cerebral complications of type 1 diabetes.
ClinicalTrials.gov NCT03286816; NCT02146404; NCT02308293
Lyoo IK, Yoon SJ, Musen G et al (2009) Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus. Arch Gen Psychiatry 66(8):878–887. https://doi.org/10.1001/archgenpsychiatry.2009.86 CrossRefPubMed
Hughes TM, Ryan CM, Aizenstein HJ et al (2013) Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complications. J Diabetes Complicat 27(6):558–564. https://doi.org/10.1016/j.jdiacomp.2013.07.001 CrossRefPubMed
Musen G, Lyoo IK, Sparks CR et al (2006) Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55(2):326–333. https://doi.org/10.2337/diabetes.55.02.06.db05-0520 CrossRefPubMed
Duarte JM (2016) Metabolism in the diabetic brain: neurochemical profiling by 1H magnetic resonance spectroscopy. J Diabetes Metab Disord 3:011
Ryan C, Vega A, Drash A (1985) Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 75:921–927 PubMed
Bischof MG, Brehm A, Bernroider E et al (2006) Cerebral glutamate metabolism during hypoglycaemia in healthy and type 1 diabetic humans. Eur J Clin Investig 36(3):164–169. https://doi.org/10.1111/j.1365-2362.2006.01615.x CrossRef
Wiegers EC, Rooijackers HM, Tack CJ, Heerschap A, de Galan BE, van der Graaf M (2016) Brain lactate concentration falls in response to hypoglycemia in patients with type 1 diabetes and impaired awareness of hypoglycemia. Diabetes 65(6):1601–1605. https://doi.org/10.2337/db16-0068 CrossRefPubMed
Wiegers EC, Rooijackers HM, Tack CJ, et al (2018) Effect of lactate administration on brain lactate levels during hypoglycemia in patients with type 1 diabetes. J Cereb Blood Flow Metab: 271678X18775884
Janssen MM, Snoek FJ, Heine RJ (2000) Assessing impaired hypoglycemia awareness in type 1 diabetes: agreement of self-report but not of field study data with the autonomic symptom threshold during experimental hypoglycemia. Diabetes Care 23(4):529–532. https://doi.org/10.2337/diacare.23.4.529 CrossRefPubMed
Provencher SW (2018) LCModel & LCMgui user’s manual. Available from http://s-provencher.com/pub/LCModel/manual/manual.pdf
Terpstra M, Moheet A, Kumar A, Eberly LE, Seaquist E, Oz G (2014) Changes in human brain glutamate concentration during hypoglycemia: insights into cerebral adaptations in hypoglycemia-associated autonomic failure in type 1 diabetes. J Cereb Blood Flow Metab 34(5):876–882. https://doi.org/10.1038/jcbfm.2014.32 CrossRefPubMedPubMedCentral
Dienel GA (2013) Astrocytic energetics during excitatory neurotransmission: what are contributions of glutamate oxidation and glycolysis? Neurochem Int 63(4):244–258. https://doi.org/10.1016/j.neuint.2013.06.015 CrossRefPubMedPubMedCentral
Duarte JM, Schuck PF, Wenk GL, Ferreira GC (2014) Metabolic disturbances in diseases with neurological involvement. Aging Dis 5:238–255 PubMed
Zhang H, Huang M, Gao L, Lei H (2015) Region-specific cerebral metabolic alterations in streptozotocin-induced type 1 diabetic rats: an in vivo proton magnetic resonance spectroscopy study. J Cereb Blood Flow Metab 35(11):1738–1745. https://doi.org/10.1038/jcbfm.2015.111 CrossRefPubMedPubMedCentral
- Elevated brain glutamate levels in type 1 diabetes: correlations with glycaemic control and age of disease onset but not with hypoglycaemia awareness status
Evita C. Wiegers
Hanne M. Rooijackers
Jack J.A. van Asten
Cees J. Tack
Bastiaan E. de Galan
Marinette van der Graaf
- Springer Berlin Heidelberg
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II